Als Therapy Development Institute

ALS Therapy Development Institute (ALS TDI) is a nonprofit biotechnology organization focused exclusively on discovering and developing effective treatments for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The institute operates a state-of-the-art research center in Cambridge, Massachusetts, and is recognized for its patient-centric approach, including its ALS Research Collaborative and direct engagement with the ALS community. ALS TDI generates revenue primarily through philanthropy, fundraising events, and partnerships rather than traditional commercial product sales. Founded in 1999 by the Heywood family after Stephen Heywood’s ALS diagnosis, the institute has become a global leader in preclinical ALS research and drug discovery. Candidates should know that ALS TDI’s mission-driven culture emphasizes innovation, transparency, and collaboration with patients and families.

Recent Posts by Als Therapy Development Institute

1-9 of 9